title: Oral anticoagulation with rivaroxaban during pregnancy: a case report.
authors: O
authors: O
authors: Königsbrügge
authors: M
authors: M
authors: Langer
authors: M
authors: M
authors: Hayde
authors: C
authors: C
authors: Ay
authors: Prof. Dr. Ingrid Pabinger, Medical University of Vienna, Department of Medicine I, Clinical Division of Haematology and Haemostaseology, Waehringer Guertel 18-20, A-1090 Vienna, Austria, Tel.: +43 1 40400 44480, Fax: +43 1 40400 40300, E-mail: ingrid.pabinger@meduniwien.ac.at.
authors: I
authors: I
authors: Pabinger
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D057915:Drug Substitution; D017984:Enoxaparin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D050498:Live Birth; D008297:Male; D009025:Morpholines / Q000008:administration & dosage* / Q000009:adverse effects; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000188:drug therapy*; D012008:Recurrence; D012307:Risk Factors; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban